BIOMAT Database Logo BIOMAT Database Logo

The natural history of obliterative bronchiolitis and occlusive vascular disease of patients following heart-lung transplantation. 1989

J P Scott, and T W Higenbottam, and C Clelland, and J A Hutter, and S Stewart, and B A Otulana, and J Wallwork
Heart-lung Transplantation Research Group, Papworth Hospital, Cambridge, England.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D001989 Bronchiolitis Obliterans Inflammation of the BRONCHIOLES leading to an obstructive lung disease. Bronchioles are characterized by fibrous granulation tissue with bronchial exudates in the lumens. Clinical features include a nonproductive cough and DYSPNEA. Bronchiolitis, Exudative,Bronchiolitis, Proliferative,Constrictive Bronchiolitis,Exudative Bronchiolitis,Proliferative Bronchiolitis,Bronchiolitides, Constrictive,Bronchiolitides, Exudative,Bronchiolitides, Proliferative,Bronchiolitis, Constrictive,Constrictive Bronchiolitides,Exudative Bronchiolitides,Proliferative Bronchiolitides
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006083 Graft Occlusion, Vascular Obstruction of flow in biological or prosthetic vascular grafts. Graft Restenosis, Vascular,Vascular Graft Occlusion,Vascular Graft Restenosis,Graft Restenoses, Vascular,Occlusion, Vascular Graft,Restenosis, Vascular Graft
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J P Scott, and T W Higenbottam, and C Clelland, and J A Hutter, and S Stewart, and B A Otulana, and J Wallwork
Obliterative bronchiolitis after lung and heart-lung transplantation.
December 1995, The Annals of thoracic surgery,
J P Scott, and T W Higenbottam, and C Clelland, and J A Hutter, and S Stewart, and B A Otulana, and J Wallwork
The immunohistopathology of obliterative bronchiolitis following lung transplantation.
October 1992, Transplantation,
J P Scott, and T W Higenbottam, and C Clelland, and J A Hutter, and S Stewart, and B A Otulana, and J Wallwork
Pathology of graft vascular disease after heart and heart-lung transplantation and its relationship to obliterative bronchiolitis.
June 1995, Transplantation proceedings,
J P Scott, and T W Higenbottam, and C Clelland, and J A Hutter, and S Stewart, and B A Otulana, and J Wallwork
Graft vessel disease and obliterative bronchiolitis after heart/lung transplantation in children.
June 1995, Transplantation proceedings,
J P Scott, and T W Higenbottam, and C Clelland, and J A Hutter, and S Stewart, and B A Otulana, and J Wallwork
Obliterative bronchiolitis after lung transplantation.
March 2000, Current opinion in pulmonary medicine,
J P Scott, and T W Higenbottam, and C Clelland, and J A Hutter, and S Stewart, and B A Otulana, and J Wallwork
Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation.
November 1996, The Annals of thoracic surgery,
J P Scott, and T W Higenbottam, and C Clelland, and J A Hutter, and S Stewart, and B A Otulana, and J Wallwork
Incidence of obliterative bronchiolitis after heart-lung transplantation in children.
January 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
J P Scott, and T W Higenbottam, and C Clelland, and J A Hutter, and S Stewart, and B A Otulana, and J Wallwork
Obliterative bronchiolitis following lung transplantation: from old to new concepts?
August 2009, Transplant international : official journal of the European Society for Organ Transplantation,
J P Scott, and T W Higenbottam, and C Clelland, and J A Hutter, and S Stewart, and B A Otulana, and J Wallwork
Obliterative bronchiolitis: the Achilles heel of lung transplantation.
October 1999, Transplantation,
J P Scott, and T W Higenbottam, and C Clelland, and J A Hutter, and S Stewart, and B A Otulana, and J Wallwork
Bronchiolitis obliterans following heart-lung and lung transplantation.
January 1994, Respiratory medicine,
Copied contents to your clipboard!